4.8 Article

Sphingosine 1-phosphate activates Weibel-Palade body exocytosis

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0400185101

Keywords

nitric oxide; ceramide; endothelial; von Willebrand factor

Funding

  1. NCRR NIH HHS [RR07002, T32 RR007002] Funding Source: Medline
  2. NHLBI NIH HHS [HL074945, R01 HL63706, P01 HL65608, P01 HL056091, P01 HL065608, P01 HL56091, K08 HL074945, R01 HL074061, R01 HL063706] Funding Source: Medline

Ask authors/readers for more resources

Sphingosine 1-phosphate (S1P) not only regulates angiogenesis, vascular permeability and vascular tone, but it also promotes vascular inflammation. However, the molecular basis for the proinflammatory effects of SIP is not understood. We now show that S1P activates endothelial cell exocytosis of Weibel-Palade bodies, releasing vasoactive substances capable of causing vascular thrombosis and inflammation. S1P triggers endothelial exocytosis in part through phospholipase C-gamma signal transduction. However, S1P also modulates endothelial cell exocytosis by activating endothelial nitric oxide synthase production of nitric oxide, which inhibits exocytosis. Thus SIP plays a dual role in regulating endothelial exocytosis, triggering pathways that both promote and inhibit endothelial exocytosis. Regulation of endothelial exocytosis may explain part of the proinflammatory effects of S1P.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available